Form 4: Tenaya Therapeutics Director Acquires Stock Options

David V. Goeddel, a director of Tenaya Therapeutics, Inc., was granted stock options to purchase 34,000 shares of common stock.

Summary

• David V. Goeddel, a director of Tenaya Therapeutics, Inc. (TNYA), acquired stock options on October 18, 2024.
• The options grant the right to buy 34,000 shares of Tenaya Therapeutics' common stock at an exercise price of $2.04 per share.
• The options were granted under the company's 2021 Equity Incentive Plan.
• The options will vest in full on May 31, 2025, or earlier if the next annual meeting of stockholders occurs before that date, contingent upon continued service to the company.
• Following the transaction, Goeddel directly owns options for 34,000 shares.

Sentiment

Score: 7

Explanation: The document reflects a standard practice of incentivizing a director with stock options, which is generally viewed positively as it aligns interests with shareholders. There are no red flags or negative aspects presented.

Positives

• The granting of stock options to a director aligns their interests with those of the shareholders, incentivizing them to work towards the company's success.
• The vesting schedule encourages continued service and commitment from the director.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the options.

Industry Context

Stock option grants are a common practice in the biotechnology industry to incentivize and retain key personnel, aligning their interests with the long-term success of the company. This is a standard form 4 filing related to that practice.

Comparison to Industry Standards

• Stock option grants are a typical component of executive compensation packages in the biotech industry.
• Companies like Amgen, Gilead, and Biogen routinely use stock options to incentivize their executives and directors.
• The vesting schedule and exercise price are generally aligned with industry norms, aiming to reward long-term value creation.

Stakeholder Impact

• The granting of stock options can positively impact shareholders by aligning the director's interests with the company's long-term success.
• Employees may view this as a positive sign of the company's commitment to its leadership.

Key Dates